유한양행

Business Overview

Yuhan is a company engaged in the manufacturing and sales of pharmaceuticals, chemicals, and daily necessities, with key products such as Lexapro, Antipurin, and DuoWell. In 2024, the company achieved a 5.7% revenue growth to 21.87 trillion won, despite challenges like geopolitical tensions and economic downturns. R&D efforts are highlighted by Lexapro's global commercialization and ongoing pipeline development, while operating profit and net income increased by 90.2% and 235.9% year-over-year, respectively.